Catalent, a global contract development and manufacturing organization (CDMO), has been recognized with two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and Social categories for its dedication to pushing the boundaries of pharmaceutical development while fostering a culture of social responsibility.
The Pharmaceutical Technology Excellence Awards honor the most significant achievements and innovations in the pharmaceutical industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies leading change and shaping the future of the industry.
Has your company won an Excellence Award?
Search to find out if your company is a winner
Catalent won the Innovation award for its groundbreaking UpTempo℠ CAR-T cell therapy platform, which addresses critical challenges in cell therapy manufacturing. Additionally, Catalent was honored in the Social category for its Catalent® Cares initiative, demonstrating a strong commitment to community engagement and social impact.
Revolutionizing cell therapy with the UpTempo℠ platform
Catalent’s UpTempo℠ platform has established a new standard in the cell therapy sector in order to de-risk and streamline the manufacturing process. The platform addresses critical challenges in cell therapy manufacturing, such as speed to market, scalability, and customization. By integrating best-in-class technologies that enable process development and manufacturing, the UpTempo℠ platform reduces inefficiencies and accelerates delivery timelines, offering a seamless pathway from discovery to patient delivery.
The UpTempo℠ platform is designed with a modular and customizable architecture, providing therapy developers with unparalleled flexibility. This allows them to tailor manufacturing solutions to specific needs without compromising on quality or compliance. For instance, developers can integrate client-specific workflows, adapting to unique therapy requirements, which is crucial in a field where personalized medicine is becoming increasingly important. This flexibility supports both autologous and allogeneic CAR-T therapies, ensuring relevance across a broad spectrum of therapies.
Catalent® Cares: A commitment to community engagement
Catalent’s dedication to social responsibility is exemplified through its Catalent® Cares initiative, which has garnered recognition for its impactful community engagement efforts. The program demonstrates the company’s commitment to supporting health, patient services, and STEM (Science, Technology, Engineering, and Mathematics) education. Catalent® Cares empowers employees across more than 40 locations worldwide to make a tangible difference in their communities.
The Catalent® Month of Service is a flagship initiative that highlights the company’s philanthropic spirit. During this month-long event in November each year, employees engage in a wide range of volunteer activities, from donating to food drives and creating care packages to building solar lamps for the homeless and recording audiobooks for people with disabilities. The 2023 edition of this initiative saw a record number of projects, with over 3,200 employees dedicating more than 4,000 hours to serve 97 charities, impacting 18,000 lives.
Catalent’s approach to community engagement is not just about numbers; it’s about fostering a culture of volunteerism that empowers employees to engage in meaningful acts of kindness. For example, employees have been involved in decorating hospices, care homes, and schools, and wrapping presents for community members during the holiday season. These activities not only enhance social impact, but also foster employee satisfaction by creating a sense of purpose and community within the workforce.
Catalent’s commitment to community engagement is a cornerstone of its corporate values, reflecting a deep-rooted belief in the power of collective action to drive positive change. By supporting initiatives that align with its mission and values, Catalent ensures that its social responsibility efforts are both impactful and sustainable, contributing to the well-being of the communities it serves.
Catalent’s dual recognition in innovation and social responsibility, thus, highlights its holistic approach to business excellence. By revolutionizing cell therapy manufacturing and fostering a culture of community engagement, Catalent is not only advancing the pharmaceutical industry but also contributing to advancements in healthcare and community well-being. The awards serve as a testament to Catalent’s vision of a future where cutting-edge innovation and social responsibility go hand in hand.
“Our mission is to develop, manufacture and supply products that help people live better and healthier lives, and we do this with a strong Patient First culture, putting patients at the center of our work, whilst engaging with our colleagues and their communities through our Catalent Cares program. We are delighted to have been recognized by the Pharmaceutical Technology Excellence Awards for some of the innovative, and philanthropic work that we do.” – Pete Williams, Vice-President, Global Environment, Health, Safety, and Sustainability, Catalent
Company Profile
Catalent is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
Contact Details
E-mail: solutions@catalent.com
+1 732-537-6200
Links
Website: www.catalent.com
